Logo image of VATE

INNOVATE CORP (VATE) Stock Fundamental Analysis

NYSE:VATE - New York Stock Exchange, Inc. - US45784J3032 - Common Stock - Currency: USD

6.83  +0.2 (+3.02%)

Fundamental Rating

1

VATE gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 50 industry peers in the Construction & Engineering industry. VATE may be in some trouble as it scores bad on both profitability and health. VATE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

VATE had negative earnings in the past year.
In the past year VATE had a positive cash flow from operations.
VATE had negative earnings in each of the past 5 years.
Of the past 5 years VATE 4 years had a positive operating cash flow.
VATE Yearly Net Income VS EBIT VS OCF VS FCFVATE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M 300M

1.2 Ratios

VATE's Return On Assets of -4.02% is on the low side compared to the rest of the industry. VATE is outperformed by 78.00% of its industry peers.
VATE has a Return On Invested Capital of 8.75%. This is in the better half of the industry: VATE outperforms 70.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for VATE is significantly below the industry average of 12.17%.
The last Return On Invested Capital (8.75%) for VATE is above the 3 year average (4.95%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -4.02%
ROE N/A
ROIC 8.75%
ROA(3y)-3.72%
ROA(5y)-6.77%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.95%
ROIC(5y)N/A
VATE Yearly ROA, ROE, ROICVATE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 300

1.3 Margins

Looking at the Operating Margin, with a value of 4.08%, VATE is in line with its industry, outperforming 48.00% of the companies in the same industry.
In the last couple of years the Operating Margin of VATE has declined.
The Gross Margin of VATE (18.86%) is comparable to the rest of the industry.
VATE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.08%
PM (TTM) N/A
GM 18.86%
OM growth 3YN/A
OM growth 5Y-8.91%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.36%
GM growth 5Y-15.84%
VATE Yearly Profit, Operating, Gross MarginsVATE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

1

2. Health

2.1 Basic Checks

VATE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for VATE has been increased compared to 1 year ago.
VATE has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, VATE has a worse debt to assets ratio.
VATE Yearly Shares OutstandingVATE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
VATE Yearly Total Debt VS Total AssetsVATE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 0.52, we must say that VATE is in the distress zone and has some risk of bankruptcy.
VATE has a Altman-Z score of 0.52. This is amonst the worse of the industry: VATE underperforms 82.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.52
ROIC/WACC1.29
WACC6.8%
VATE Yearly LT Debt VS Equity VS FCFVATE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

VATE has a Current Ratio of 0.81. This is a bad value and indicates that VATE is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.81, VATE is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
VATE has a Quick Ratio of 0.81. This is a bad value and indicates that VATE is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.77, VATE is not doing good in the industry: 78.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.77
VATE Yearly Current Assets VS Current LiabilitesVATE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

0

3. Growth

3.1 Past

VATE shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.72%.
VATE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -22.20%.
Measured over the past years, VATE shows a decrease in Revenue. The Revenue has been decreasing by -6.36% on average per year.
EPS 1Y (TTM)-9.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-975%
Revenue 1Y (TTM)-22.2%
Revenue growth 3Y25.68%
Revenue growth 5Y-6.36%
Sales Q2Q%-34.46%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VATE Yearly Revenue VS EstimatesVATE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
VATE Yearly EPS VS EstimatesVATE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2023 0 10 -10 20 30

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VATE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VATE Price Earnings VS Forward Price EarningsVATE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VATE indicates a rather cheap valuation: VATE is cheaper than 86.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.99
VATE Per share dataVATE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for VATE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INNOVATE CORP

NYSE:VATE (4/28/2025, 8:04:00 PM)

6.83

+0.2 (+3.02%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)03-31 2025-03-31/amc
Earnings (Next)05-05 2025-05-05
Inst Owners21.32%
Inst Owner Change-1.26%
Ins Owners52.74%
Ins Owner Change-143.22%
Market Cap90.70M
Analysts82.86
Price TargetN/A
Short Float %8.03%
Short Ratio5.84
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.11
Dividend Growth(5Y)0.76%
DP-3.35%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.08
P/FCF N/A
P/OCF 9.97
P/B N/A
P/tB N/A
EV/EBITDA 8.99
EPS(TTM)-0.47
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.75
FCFYN/A
OCF(TTM)0.69
OCFY10.03%
SpS83.37
BVpS-12.37
TBVpS-34.89
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.02%
ROE N/A
ROCE 11.08%
ROIC 8.75%
ROICexc 9.94%
ROICexgc 59.32%
OM 4.08%
PM (TTM) N/A
GM 18.86%
FCFM N/A
ROA(3y)-3.72%
ROA(5y)-6.77%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.95%
ROIC(5y)N/A
ROICexc(3y)5.63%
ROICexc(5y)N/A
ROICexgc(3y)24.72%
ROICexgc(5y)N/A
ROCE(3y)6.27%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-8.91%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.36%
GM growth 5Y-15.84%
F-Score4
Asset Turnover1.24
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 6.41
Cap/Depr 57.75%
Cap/Sales 1.72%
Interest Coverage 0.93
Cash Conversion 11.65%
Profit Quality N/A
Current Ratio 0.81
Quick Ratio 0.77
Altman-Z 0.52
F-Score4
WACC6.8%
ROIC/WACC1.29
Cap/Depr(3y)52.64%
Cap/Depr(5y)57.69%
Cap/Sales(3y)1.42%
Cap/Sales(5y)1.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-975%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-22.2%
Revenue growth 3Y25.68%
Revenue growth 5Y-6.36%
Sales Q2Q%-34.46%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y54.79%
EBIT growth 3YN/A
EBIT growth 5Y-8.4%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-222.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-65.66%
OCF growth 3Y-65.54%
OCF growth 5Y-39.31%